Functional screen of Inflammatory bowel disease genes reveals key epithelial functions: Agilent Targeted Dataset
Download from source ↗Dataset overview
Functional screen of inflammatory bowel disease genes reveals key epithelial functions.
Abstract
<h4>Background</h4>Genetic studies have been tremendously successful in identifying genomic regions associated with a wide variety of phenotypes, although the success of these studies in identifying causal genes, their variants, and their functional impacts has been more limited.<h4>Methods</h4>We identified 145 genes from IBD-associated genomic loci having endogenous expression within the intestinal epithelial cell compartment. We evaluated the impact of lentiviral transfer of the open reading frame (ORF) of these IBD genes into the HT-29 intestinal epithelial cell line via transcriptomic analyses. By comparing the genes in which expression was modulated by each ORF, as well as the functions enriched within these gene lists, we identified ORFs with shared impacts and their putative disease-relevant biological functions.<h4>Results</h4>Analysis of the transcriptomic data for cell lines expressing the ORFs for known causal genes such as HNF4a, IFIH1, and SMAD3 identified functions consistent with what is already known for these genes. These analyses also identified two major clusters of genes: Cluster 1 contained the known IBD causal genes IFIH1, SBNO2, NFKB1, and NOD2, as well as genes from other IBD loci (ZFP36L1, IRF1, GIGYF1, OTUD3, AIRE and PITX1), whereas Cluster 2 contained the known causal gene KSR1 and implicated DUSP16 from another IBD locus. Our analyses highlight how multiple IBD gene candidates can impact on epithelial structure and function, including the protection of the mucosa from intestinal microbiota, and demonstrate that DUSP16 acts a regulator of MAPK activity and contributes to mucosal defense, in part via its regulation of the polymeric immunoglobulin receptor, involved in the protection of the intestinal mucosa from enteric microbiota.<h4>Conclusions</h4>This functional screen, based on expressing IBD genes within an appropriate cellular context, in this instance intestinal epithelial cells, resulted in changes to the cell's transcriptome that are relevant to their endogenous biological function(s). This not only helped in identifying likely causal genes within genetic loci but also provided insight into their biological functions. Furthermore, this work has highlighted the central role of intestinal epithelial cells in IBD pathophysiology, providing a scientific rationale for a drug development strategy that targets epithelial functions in addition to the current therapies targeting immune functions.
doi:10.1186/s13073-021-00996-7 ↗ PMID 34758847 ↗ PMC8582123 ↗
Study facts
- Organism
- Homo sapiens
- Platform
- Agilent iGenex v.2 gene expression array
- Age group
- —
- Disease groups
- —
- Anatomical sites
- —
Data availability
Specific data assets have not been resolved from the source yet — see the source repository below for the full file listing.
Strengths & limitations for reuse
Strengths
- Sample counts are documented
Limitations
- Not documented: raw reads are advertised
- Not documented: feature/otu tables are advertised
- Not documented: taxonomic tables are advertised
- Not documented: participant counts are documented
Extraction evidence & provenance
Each extracted field is shown with the source excerpt and location used to resolve it.
Assay
| Field | Value | Evidence |
|---|---|---|
assay.platform |
Agilent iGenex v.2 gene expression array |
The Agilent iGenex v.2 gene expression array (Agilent, Santa Clara, CA) is a custom-designed array Section |
Data_Assets
| Field | Value | Evidence |
|---|---|---|
data_assets.pipeline_or_tool_versions |
True |
We used Limma v3.26.9 and sva v3.18.0 packages (Bioconductor v3.1-3.2) to load the fluorescence intensity files and handle the data into R V3.2.0. Section |
data_assets.qc_or_negative_controls_reported |
True |
After quality control, 426 samples were included in the analysis for the Agilent platform Section |
Specimens
| Field | Value | Evidence |
|---|---|---|
specimens.body_site |
human colonic epithelial cell line (HT-29) |
The colorectal adenocarcinoma cell line HT-29 ... was maintained Section |
specimens.number_of_samples |
426 |
After quality control, 426 samples were included in the analysis for the Agilent platform Section |